MaxLinear price target raised to $28 from $25 at Benchmark
Benchmark analyst David Williams raised the firm’s price target on MaxLinear (MXL) to $28 from $25 and keeps a Buy rating on the shares. Despite share underperformance last year, MaxLinear remains a Benchmark Best Idea into 2026 and the firm believes MaxLinear represents “one of the best connectivity-focused semiconductor opportunities,” the analyst tells investors.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.